Clinical Trial Update: Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial (V501-011) evaluating the safety of Merck's HPV vaccine in women for cervical cancer and genital warts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Warts

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cervical Cancer, Genital Warts | Phase 3 | Status: COMPLETED